Episodes of Keratitis During Treatment with Baricitinib for Alopecia Areata

The document discusses the potential ocular side effects associated with the use of JAK inhibitors, such as Baricitinib, in treating alopecia areata. Although these side effects, including episodes of keratitis, are rare, they are not unheard of. A causal link between JAK inhibitors and ocular side effects has not been established. Clinicians are advised to be vigilant about these possible adverse events and report them to drug safety agencies. In some cases, discontinuing the drug and switching to an alternative treatment may be necessary.